Literature DB >> 9336508

The impact of surgical complications after liver transplantation on resource utilization.

R S Brown1, N L Ascher, J R Lake, J C Emond, P Bacchetti, H B Randall, J P Roberts.   

Abstract

OBJECTIVE: To evaluate the impact of surgical complications on length of stay and hospital charges after liver transplantation.
DESIGN: A retrospective economic evaluation of the outcomes during initial hospitalization after liver transplantation.
SETTING: University hospital treating referred patients. PATIENTS: The study population was 109 patients undergoing 111 liver transplantations during fiscal year 1993. MAIN OUTCOME MEASURES: Hospital charges and length of stay during the initial hospitalization after liver transplantation. Multivariate regression methods were used to analyze the impact of surgical complications on costs.
RESULTS: Of the 111 transplantations, 30 (27%) had a surgical complication that required a return to the operating room during the initial hospitalization. The effect of a surgical complication was to increase the mean hospital charges (excluding physician charges) from $150,092 to $347,728 (difference of mean, $197,636; confidence interval of difference, $114,153 to $319,326). The median length of stay was 16 days for patients without complications and 45 days for those with complications. Univariate and multivariate models suggested that surgical complications had the greatest effect on length of stay and hospital charges among the factors studied. Complications tended to occur more frequently among patients with United Network for Organ Sharing (UNOS) status 1 (42% vs 22%), but this did not reach statistical significance (P = .09).
CONCLUSIONS: Surgical complications after liver transplantation have a marked impact on the cost of the procedure. The magnitude of this effect is greater than that of UNOS status, presence of rejection, or other demographic or clinical factors studied. Complications tend to occur in the most ill patients. Identifying strategies to reduce the risk of complications, particularly in patients with UNOS status 1, likely can reduce the cost of transplantation.

Entities:  

Mesh:

Year:  1997        PMID: 9336508     DOI: 10.1001/archsurg.1997.01430340052008

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  10 in total

1.  Temporal trends in early clinical outcomes and health care resource utilization for liver transplantation in the United States.

Authors:  John E Scarborough; Ricardo Pietrobon; Carlos E Marroquin; Janet E Tuttle-Newhall; Paul C Kuo; Bradley H Collins; Dev M Desai; Theodore N Pappas
Journal:  J Gastrointest Surg       Date:  2007-01       Impact factor: 3.452

Review 2.  Interferon alfacon-1: a review of its pharmacology and therapeutic efficacy in the treatment of chronic hepatitis C.

Authors:  E B Melian; G L Plosker
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation.

Authors:  Robert M Merion; Tempie H Shearon; Carl L Berg; James E Everhart; Michael M Abecassis; Abraham Shaked; Robert A Fisher; James F Trotter; Robert S Brown; Norah A Terrault; Paul H Hayashi; Johnny C Hong
Journal:  Ann Surg       Date:  2010-03       Impact factor: 12.969

4.  The role of interventional radiology in biliary complications after orthotopic liver transplantation: a single-center experience.

Authors:  Enrico Maria Civelli; Roberta Meroni; Guido Cozzi; Marco Milella; Laura Suman; Ruggero Vercelli; Aldo Severini
Journal:  Eur Radiol       Date:  2003-11-25       Impact factor: 5.315

5.  Risk Factors for Transfusion after Orthotopic Liver Transplantation.

Authors:  Ana Paula Hitomi Yokoyama; José Mauro Kutner; Araci Massami Sakashita; Cristiane Yoshie Nakazawa; Tatiana Almeida Omura de Paula; Raffael Perreira Cezar Zamper; Pamella Tung Pedroso; Marcio Dias de Almeida; Sergio Paiva Meira Filho; Fernanda Andrade Orsi
Journal:  Transfus Med Hemother       Date:  2019-04-03       Impact factor: 3.747

6.  Outcomes of patients with benign liver diseases undergoing living donor versus deceased donor liver transplantation.

Authors:  Chuan Li; Kai Mi; Tian fu Wen; Lu nan Yan; Bo Li; Jia ying Yang; Ming qing Xu; Wen tao Wang; Yong gang Wei
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

7.  Risk Factors Associated with Reoperation for Bleeding following Liver Transplantation.

Authors:  Maxwell A Thompson; David T Redden; Lindsey Glueckert; A Blair Smith; Jack H Crawford; Keith A Jones; Devin E Eckhoff; Stephen H Gray; Jared A White; Joseph Bloomer; Derek A DuBay
Journal:  HPB Surg       Date:  2014-11-20

8.  Predictors of micro-costing components in liver transplantation.

Authors:  Luciana Bertocco de Paiva Haddad; Liliana Ducatti; Luana Regina Baratelli Carelli Mendes; Wellington Andraus; Luiz Augusto Carneiro D'Albuquerque
Journal:  Clinics (Sao Paulo)       Date:  2017-06       Impact factor: 2.365

9.  Emergency department visits and unanticipated readmissions after liver transplantation: A retrospective observational study.

Authors:  Seung-Young Oh; Jeong Moo Lee; Hannah Lee; Chul-Woo Jung; Nam-Joon Yi; Kwang-Woong Lee; Kyung-Suk Suh; Ho Geol Ryu
Journal:  Sci Rep       Date:  2018-03-06       Impact factor: 4.379

10.  Randomized controlled multicenter trial on the effectiveness of the collagen hemostat Sangustop® compared with a carrier-bound fibrin sealant during liver resection (ESSCALIVER study, NCT00918619).

Authors:  C Moench; A L Mihaljevic; V Hermanutz; W E Thasler; K Suna; M K Diener; D Seehofer; H J Mischinger; B Jansen-Winkeln; H P Knaebel; W O Bechstein
Journal:  Langenbecks Arch Surg       Date:  2014-06-01       Impact factor: 3.445

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.